What does this research mean for the field?

While ACE inhibitors are beneficial for hypertension, heart failure, and nephropathies, they can induce acute renal failure in patients with compromised renal perfusion or highly Angiotensin II-dependent glomerular filtration rates, necessitating targeted preventive strategies. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To examine the renal hemodynamic actions of ACE inhibitors, the pathophysiology of drug-induced functional acute renal failure and hyperkalemia, and the primary clinical risk factors.

October 16, 2001CirculationOpen Access

Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy

View Full Paper

Ask AI

Bookmark

Why the study?

What are the pathophysiological mechanisms and risk factors for ACE inhibitor-induced functional acute renal failure in patients with hypertension, CHF, and nephropathies?

Key Points

To examine the renal hemodynamic actions of ACE inhibitors, the pathophysiology of drug-induced functional acute renal failure and hyperkalemia, and the primary clinical risk factors.
Reviewed physiological mechanisms and clinical data on ACE inhibitor therapy in hypertension, congestive heart failure, and chronic nephropathies.
Analyzed hemodynamic determinants of glomerular filtration rate, focusing on the roles of mean arterial pressure, renal perfusion pressure, and angiotensin II dependency.
ACE inhibitors routinely improve renal blood flow and reduce progressive renal damage, but can induce acute functional renal insufficiency or hyperkalemia when filtration is critically dependent on angiotensin II.
Preexisting hypotension, reduced cardiac filling pressures, extracellular fluid volume depletion, and bilateral or solitary renal artery stenosis represent the predominant predisposing factors for acute renal decline.
Adverse renal responses typically manifest shortly after treatment initiation, although onset may occasionally occur after months or years of uneventful therapy.

Structured PICO

What are the pathophysiological mechanisms and risk factors for ACE inhibitor-induced functional acute renal failure in patients with hypertension, CHF, and nephropathies?

Population

Patients receiving angiotensin converting enzyme (ACE) inhibitors, including those with hypertension, congestive heart failure (CHF), and diabetic or nondiabetic nephropathies

Intervention

Angiotensin converting enzyme (ACE) inhibitor therapy

Outcome

Development of functional acute renal failure (ARF) or hyperkalemiasafety

Understanding the risk factors and mechanisms of ACE inhibitor-induced acute renal failure is critical for implementing preventive strategies and optimizing therapy in vulnerable patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Alerts clinicians to monitor renal function and potassium with ACE inhibitors in low-perfusion states; leaves open targeted prevention trials in hypertension and heart failure.

Cite This Study

Schoolwerth et al. (2001) studied this question.

synapsesocial.com/papers/6a1d19caba65f5ee325dcb5f https://doi.org/10.1161/hc4101.096153

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Alerts clinicians to monitor renal function and potassium with ACE inhibitors in low-perfusion states; leaves open targeted prevention trials in hypertension and heart failure.

Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider